Epidemiological Findings

Molecular and Integrative Toxicology

Volumn , Issue , 2015, Pages 305-335

  Khalil, Naila ^a   Lee, Miryoung ^a   Steenland, Kyle ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Epidemiology; Perfluoroalkyl; Perfluorohexane sulfonate (PFHxS); Perfluorononanoic acid (PFNA); Perfluorooctane sulfonic acid (PFOS); Perfluorooctanoic acid (PFOA); Polyfluoroalkyl substances (PFAS)

Indexed keywords

EID: 85091505154     PISSN: 21684219     EISSN: 21684235     Source Type: Book Series    
DOI: 10.1007/978-3-319-15518-0_13     Document Type: Chapter

References (123)

1. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR (2007) Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670–1676
2. Bandaru P, Shankar A (2011) Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol 2011:604715. doi:10.1155/2011/604715
3. Barry V, Winquist A, Steenland K (2013) Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121:1313–1318
4. Barry V, Darrow LA, Klein M, Winquist A, Steenland K (2014) Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure. Environ Res 132:62–69
5. Biegel LB, Hurtt ME, Frame SR, O’Connor JC, Cook JC (2001) Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60:44–55
6. Bloom MS, Kannan K, Spliethoff HM, Tao L, Aldous KM, Vena JE (2010) Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol Behav 99:240–245
7. C8 Science Panel (2011) Probable link evaluation of pregnancy-induced hypertension and preeclampsia. Available: http://www.c8sciencepanel.org/pdfs/Probable_Link_C8_ PIH_5Dec2011.pdf. Accessed 30 Sept 2014
8. C8 Science Panel (2012a) Probable link evaluation for liver disease. Available: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_Liver_29Oct2012.pdf. Accessed 20 Sept 2014
9. C8 Science Panel (2012b) Probable link evaluation of autoimmune disease. Available: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_Autoimmune_Disease_30Jul2012.pdf. Accessed 25 Sept 2014
10. C8 Science Panel (2012c) Probable link evaluation of kidney disease. Available: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_Kidney_29Oct2012.pdf. Accessed 25 Sept 2014
11. C8 Science Panel (2012d) Probable link evaluation of osteoarthritis. Available: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_Osteoarthritis_29Oct2012v2.pdf. Accessed 25 Sept 2014
12. C8 Science Panel (2012e) Probable link evaluation for Parkinson’s disease. Available: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_Parkinsons_Disease_29Oct2012.pdf. Accessed 20 Sept 2014
13. Cain L, Shankar A, Ducatman AM, Steenland K (2010) The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant 25:3593–3599
14. Costa G, Sartori S, Consonni D (2009) Thirty years of medical surveillance in perfluorooctanoic acid production workers. J Occup Environ Med 51:364–372
15. Darrow LA, Stein CR, Steenland K (2013) Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005–2010. Environ Health Perspect 121:1207–1213
16. Darrow LA, Howards PP, Winquist A, Steenland K (2014) PFOA and PFOS serum levels and miscarriage risk. Epidemiology 25:505–512
17. Dewitt JC, Copeland CB, Strynar MJ, Luebke RW (2008) Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116:644–650
18. Dewitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39:76–94
19. Dong GH, Tung KY, Tsai CH, Liu MM, Wang D, Liu W, Jin YH, Hsieh WS, Lee YL, Chen PC (2013) Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect 121(507–13):513e1–513e8
20. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM (2006) Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48:759–770
21. Eriksen KT, Sorensen M, Mclaughlin JK, Lipworth L, Tjonneland A, Overvad K, Raaschou-Nielsen O (2009) Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101:605–609
22. Eriksen KT, Raaschou-Nielsen O, Mclaughlin JK, Lipworth L, Tjonneland A, Overvad K, Sorensen M (2013) Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. PLoS ONE 8:e56969
23. Fei C, Olsen J (2011) Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Environ Health Perspect 119:573–578
24. Fei C, Mclaughlin JK, Tarone RE, Olsen J (2007) Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677–1682
25. Fei C, Mclaughlin JK, Lipworth L, Olsen J (2008) Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect 116:1391–1395
26. Fei C, Mclaughlin JK, Lipworth L, Olsen J (2009) Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200–1205
27. Fei C, Weinberg CR, Olsen J (2012) Commentary: perfluorinated chemicals and time to pregnancy: a link based on reverse causation? Epidemiology 23:264–266
28. Fisher M, Arbuckle TE, Wade M, Haines DA (2013) Do perfluoroalkyl substances affect metabolic function and plasma lipids?–Analysis of the 2007–2009, Canadian Health Measures Survey (CHMS) Cycle 1. Environ Res 121:95–103
29. Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, Armstrong B (2013) Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluo-rooctanesulfonic acid. Epidemiology 24:569–576
30. Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM (2010) Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med 164:860–869
31. Gallo V, Leonardi G, Genser B, Lopez-Espinosa MJ, Frisbee SJ, Karlsson L, Ducatman AM, Fletcher T (2012) Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ Health Perspect 120:655–660
32. Gallo V, Leonardi G, Brayne C, Armstrong B, Fletcher T (2013) Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study. BMJ Open 3:e002414. doi:10.1136/bmjopen-2012-002414
33. Geiger SD, Xiao J, Shankar A (2013) Positive association between perfluoroalkyl chemicals and hyperuricemia in children. Am J Epidemiol 177:1255–1262
34. Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A (2014) The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 98:78–83
35. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, Heilmann C (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:391–397
36. Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, Van Loveren H, Lovik M, Nygaard UC (2013) Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 10:373–379
37. Gump BB, Wu Q, Dumas AK, Kannan K (2011) Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol 45:8151–8159
38. Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, Henriksen TB, Olsen SF (2012) Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 120:668–673
39. Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I (2010) Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol 20:589–597
40. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM (2010) Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12–15 years of age. Environ Health Perspect 118:1762–1767
41. Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, Hiatt RA (2014) Perfluoroalkyl chemicals and asthma among children 12–19 years of age: NHANES (1999–2008). Environ Health Perspect 122(10):1129–1133
42. Innes KE, Ducatman AM, Luster MI, Shankar A (2011) Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol 174:440–450
43. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, Uno A, Saijo Y, Sata F, Yoshimura Y, Kishi R, Nakazawa H (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204–1207
44. Jain RB (2013) Association between thyroid profile and perfluoroalkyl acids: data from NHNAES 2007–2008. Environ Res 126:51–59
45. Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jorgensen N (2009) Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 117:923–927
46. Joensen UN, Veyrand B, Antignac JP, Jensen MB, Petersen JH, Marchand P, Skakkebaek NE, Andersson AM, Le Bizec B, Jorgensen N (2014) PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Hum Reprod, 8 May [Epub ahead of print]
47. Johnson PI, Sutton P, Atchley DS, KOUSTAS E, Lam J, Sen S, Robinson KA, Axelrad DA, Woodruff TJ (2014) The navigation guide-evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 122:1028–1039
48. Karnes C, Winquist A, Steenland K (2014) Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid. Environ Res 128:78–83
49. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM (2011) Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol 45:8037–8045
50. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM (2011a) Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 36:403–410
51. Knox SS, Jackson T, Javins B, Frisbee SJ, Shankar A, Ducatman AM (2011b) Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab 96:1747–1753
52. Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, Halldorsson TI, Becher G, Haug LS, Toft G (2013) Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction. Hum Reprod 28:3337–3348
53. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, SEED J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394
54. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22
55. Lin CY, Chen PC, Lin YC, Lin LY (2009) Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care 32:702–707
56. Lin CY, Lin LY, Chiang CK, Wang WJ, Su YN, Hung KY, Chen PC (2010) Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol 105:1354–1363
57. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Chen CY, Hsu SH, Chien KL, Sung FC, Chen PC, Su TC (2011) Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan. Environ Sci Technol 45:10691–10698
58. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SH, Chien KL, Liao CC, Sung FC, Chen PC, Su TC (2013) The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J Hazard Mater 244–245:637–644
59. Lin LY, Wen LL, Su TC, Chen PC, Lin CY (2014) Negative association between serum perfluorooctane sulfate concentration and bone mineral density in US premenopausal women: NHANES, 2005–2008. J Clin Endocrinol Metab 99:2173–2180
60. Lind L, Zethelius B, Salihovic S, Van Bavel B, Lind PM (2014) Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly. Diabetologia 57:473–479
61. Liu C, Yu K, Shi X, Wang J, Lam PK, Wu RS, Zhou B (2007) Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat Toxicol 82:135–143
62. Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T (2014) Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci 138:76–88
63. Lopez-Espinosa MJ, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, Ducatman A, Leonardi G (2011) Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 45:8160–8166
64. Lopez-Espinosa MJ, Mondal D, Armstrong B, Bloom MS, Fletcher T (2012) Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspect 120:1036–1041
65. Lundin JI, Alexander BH, Olsen GW, Church TR (2009) Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20:921–928
66. Lyngso J, Ramlau-Hansen CH, Hoyer BB, Stovring H, Bonde JP, Jonsson BA, Lindh CH, Pedersen HS, Ludwicki JK, Zviezdai V, Toft G (2014) Menstrual cycle characteristics in fertile women from Greenland, Poland and Ukraine exposed to perfluorinated chemicals: a cross-sectional study. Hum Reprod 29:359–367
67. Macneil J, Steenland NK, Shankar A, Ducatman A (2009) A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109:997–1003
68. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS (2010) Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686–692
69. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J (2007) Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80:643–648
70. Min JY, Lee KJ, Park JB, Min KB (2012) Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults. Occup Environ Med 69:658–662
71. Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, Foster WG (2008) Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108:56–62
72. Nelson JW, Hatch EE, Webster TF (2010) Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197–202
73. Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA (2009) The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 27:231–238
74. Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmett EA (2010) Congenital anomalies, labor/ delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 29:147–155
75. Okada E, Sasaki S, Saijo Y, Washino N, Miyashita C, Kobayashi S, Konishi K, Ito YM, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, Kishi R (2012) Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. Environ Res 112:118–125
76. Olsen GW, Zobel LR (2007) Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231–246
77. Olsen GW, Burris JM, Burlew MM, Mandel JH (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260–270
78. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305
79. Olsen GW, Ehresman DJ, Buehrer BD, Gibson BA, Butenhoff JL, Zobel LR (2012) Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities. J Occup Environ Med 54:974–983
80. Power MC, Webster TF, Baccarelli AA, Weisskopf MG (2013) Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey. Neuroepidemiology 40:125–132
81. Qian Y, Ducatman A, Ward R, Leonard S, Bukowski V, Lan Guo N, Shi X, Vallyathan V, Castranova V (2010) Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A 73:819–836
82. Raymer JH, Michael LC, Studabaker WB, Olsen GW, Sloan CS, Wilcosky T, Walmer DK (2012) Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reprod Toxicol 33:419–427
83. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC (2007a) Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 49:1086–1096
84. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR (2007b) Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49:872–879
85. Sakr CJ, Symons JM, Kreckmann KH, Leonard RC (2009) Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ Med 66:699–703
86. Savitz DA, Stein CR, Bartell SM, Elston B, Gong J, Shin HM, Wellenius GA (2012a) Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 23:386–392
87. Savitz DA, Stein CR, Elston B, Wellenius GA, Bartell SM, Shin HM, Vieira VM, Fletcher T (2012b) Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley. Environ Health Perspect 120:1201–1207
88. Shankar A, Xiao J, Ducatman A (2011a) Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am J Epidemiol 174:893–900
89. Shankar A, Xiao J, Ducatman A (2011b) Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin Epidemiol 3:251–258
90. Shankar A, Xiao J, Ducatman A (2012) Perfluorooctanoic acid and cardiovascular disease in US adults. Arch Intern Med 172:1397–1403
91. Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM (2011) Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119:1760–1765
92. Simpson C, Winquist A, Lally C, Steenland K (2013) Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant. Environ Res 127:22–28
93. Smits JE, Nain S (2013) Immunomodulation and hormonal disruption without compromised disease resistance in perfluorooctanoic acid (PFOA) exposed Japanese quail. Environ Pollut 179:13–18
94. So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K, Lam PK (2006) Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 40:2924–2929
95. Specht IO, Hougaard KS, Spano M, Bizzaro D, Manicardi GC, Lindh CH, Toft G, Jonsson BA, Giwercman A, Bonde JP (2012) Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances – a study of spouses of pregnant women in three geographical regions. Reprod Toxicol 33:577–583
96. Starling AP, Engel SM, Whitworth KW, Richardson DB, Stuebe AM, Daniels JL, Haug LS, Eggesbo M, Becher G, Sabaredzovic A, Thomsen C, Wilson RE, Travlos GS, Hoppin JA, Baird DD, Longnecker MP (2014) Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. Environ Int 62:104–112
97. Steenland K, Woskie S (2012) Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 176:909–917
98. Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V (2009) Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol 170:1268–1278
99. Steenland K, Fletcher T, Savitz DA (2010a) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100–1108
100. Steenland K, Tinker S, Shankar A, Ducatman A (2010b) Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect 118:229–233
101. Steenland K, Zhao L, Winquist A, Parks C (2013) Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect 121:900–905
102. Stein CR, Savitz DA (2011) Serum perfluorinated compound concentration and attention deficit/ hyperactivity disorder in children 5–18 years of age. Environ Health Perspect 119:1466–1471
103. Stein CR, Savitz DA, Dougan M (2009) Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170:837–846
104. Stein CR, Savitz DA, Bellinger DC (2013) Perfluorooctanoate and neuropsychological outcomes in children. Epidemiology 24:590–599
105. Stein CR, Savitz DA, Bellinger DC (2014a) Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6–12-year-old children. Paediatr Perinat Epidemiol 28:146–156
106. Stein CR, Savitz DA, Elston B, Thorpe PG, Gilboa SM (2014b) Perfluorooctanoate exposure and major birth defects. Reprod Toxicol 47:15–20
107. Taylor BK, Kriedt C, Nagalingam S, Dadia N, Badr M (2005) Central administration of perfluorooctanoic acid inhibits cutaneous inflammation. Inflamm Res 54:235–242
108. Taylor KW, Hoffman K, Thayer KA, Daniels JL (2014) Polyfluoroalkyl chemicals and menopause among women 20–65 years of age (NHANES). Environ Health Perspect 122:145–150
109. Uhl SA, James-Todd T, Bell ML (2013) Association of osteoarthritis with perfluorooctanoate and perfluorooctane sulfonate in NHANES 2003–2008. Environ Health Perspect 121:447–452
110. Vieira VM, Hoffman K, Shin HM, Weinberg JM, Webster TF, Fletcher T (2013) Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 121:318–323
111. Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, Travlos G, King D, Hoppin JA, Rogan WJ, Longnecker MP (2013) Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health 12:76
112. Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, Longnecker MP, Wang SL (2014) Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ Health Perspect 122:529–534
113. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, Kishi R (2009) Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117:660–667
114. Watkins DJ, Josson J, Elston B, Bartell SM, Shin HM, Vieira VM, Savitz DA, Fletcher T, Wellenius GA (2013) Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect 121:625–630
115. Webster GM, Venners SA, Mattman A, Martin JW (2014) Associations between Perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Environ Res 133:338–347
116. Wen LL, Lin LY, Su TC, Chen PC, Lin CY (2013) Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007–2010. J Clin Endocrinol Metab 98:E1456–E1464
117. White SS, Fenton SE, Hines EP (2011) Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol 127:16–26
118. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Longnecker MP (2012) Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 23:257–263
119. Winquist A, Steenland K (2014a) Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect, 26 Sept 2014 [Epub ahead of print]
120. Winquist A, Steenland K (2014b) Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 25:255–264
121. Winquist A, Lally C, Shin HM, Steenland K (2013) Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Environ Health Perspect 121:893–899
122. Woskie SR, Gore R, Steenland K (2012) Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg 56:1025–1037
123. Yamaguchi M, Arisawa K, Uemura H, Katsuura-Kamano S, Takami H, Sawachika F, Nakamoto M, Juta T, Toda E, Mori K, Hasegawa M, Tanto M, Shima M, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, Satoh H (2013) Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population. J Occup Health 55:184–194